Matthew Sage, MD
Dermatology · Richmond, VANPI 1861754426
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AbbVie at 33.5% of the total. Reporting peaked in 2019 at $358 and has fallen 94.7% since, to $19 in 2025. That places this record below the midpoint for dermatology clinicians in VA, where the typical reported total is $1,785.
Across 37 payments — averaging $21.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$261
- Prugen, Inc. Pharmaceuticals$150
- Novartis$99
- Galderma Laboratories, L.p.$58
- LEO Pharma Inc.$55
- Sun Pharmaceutical Industries Inc.$29
- plus $127 from 7 others
What the payments were for
- Food & beverage$778100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $261 |
| Prugen, Inc. Pharmaceuticals | 2 | $150 |
| Novartis | 6 | $99 |
| Galderma Laboratories, L.p. | 4 | $58 |
| LEO Pharma Inc. | 3 | $55 |
| Sun Pharmaceutical Industries Inc. | 2 | $29 |
| Sanofi | 1 | $21 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $19 |
| UCB, Inc. | 1 | $19 |
| Pfizer | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Amgen | 1 | $16 |
| VYNE Pharmaceuticals Inc. | 1 | $16 |
How this compares
$778 in reported general payments places this provider in the 30th percentile of 396 dermatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 13 | $47,578 |
| Tacrolimus | 19 | $3,106 |
| Fluorouracil | 35 | $2,282 |
| Metronidazole | 48 | $2,258 |
| Triamcinolone Acetonide | 283 | $2,046 |
| Ketoconazole | 93 | $1,434 |
| Clobetasol Propionate | 36 | $1,311 |
| Clindamycin Phosphate | 21 | $738 |
| Ciclopirox | 15 | $568 |
| Doxycycline Hyclate | 32 | $476 |
| Hydrocortisone | 96 | $445 |
| Mometasone Furoate | 31 | $387 |
| Mupirocin | 44 | $245 |
| ValacyclovirValacyclovir Hcl | 11 | $240 |
| Cephalexin | 18 | $68 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Richmond
- Mohammed DanyRichmond$74K
- Suzanne PeckRichmond$51K
- Melissa KingRichmond$15K
- Victoria GrossRichmond$14K
- Margaret TerhuneRichmond$13K
- Naiem IssaVienna$2M
- Saurabh SinghFairfax$1.7M
- Diego DasilvaVirginia Beach$1.1M
- Vishal PatelLeesburg$719K
- Cyndi Torosky TommasoVirginia Beach$717K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.